Cystic fibrosis (CF) respiratory epithelia exhibit abnormal anion transport that may be linked to abnormal lung defense. In these studies, we investigated whether primary cultures of CF respiratory epithelial cells regulate abnormally the sulfate content of high molecular weight glycoconjugates (HMG) 
Introduction
Cystic fibrosis (CF)' is a genetic disease characterized by abnormal epithelial electrolyte transport. Failure to secrete Cland excessive reabsorption of Na' in the large airways' epithelium ofCF patients (1-6) could lead to dehydration and accumulation of secretions. However, these abnormalities alone are unlikely to explain the progressive course of airway obstruction and persistent infection with specific microorganisms such as Staphylococcus aureus and Pseudomonas aeruginosa, because failure to clear secretions secondary to dysmotile cilia (7) generally is associated with less severe airway disease.
Previous studies showed that high molecular weight glycoconjugates (HMG) secreted by CF airways in situ (8) and in organ culture (9, 10) are oversulfated. However, it has not been clear whether this is an acquired abnormality ( I 1) or whether it is related to the basic defect in CF. Recently, Yankaskas et al. (12) demonstrated that CF nasal epithelial cells in primary culture retain epithelial cell polarity and the electrolyte transport properties that distinguish CF from normal or disease control (DC) subjects. We have demonstrated that these cultured cells produce and release sulfated HMG (13) . We now report that the HMG synthesized by cultured CF nasal epithelial cells are more highly sulfated as compared with the HMG produced by normal or DC cells.
Methods
Human tissues. Nasal polyps and turbinates surgically removed from patients with allergic rhinitis (DC) or no known inflammatory process in the upper airway (normal) were used for these studies. CF patients had elevated levels of sweat chloride, typical pulmonary disease, and pancreatic insufficiency. DC patients had seasonal rhinitis and eosinophilia. Normal patients had obstructive sleep apnea or anatomic airway narrowing but no atopic symptoms (6) . Details concerning tissue donors are included in figure legends. Tissues were rinsed in normal saline and transported to the laboratory in MEM at 4°C by ground (local hospitals) or overnight air (distant hospitals) carrier.
Culture conditions. The epithelial cells were dissociated from freshly excised nasal tissues by incubation in 0.1b% protease (Type XIV, Sigma Chemical Co.) for 16 h and cultured on collagen matrices in Ham's F-12 medium supplemented with hormones as described (12) . When cultured cells reached confluence, the media were changed to a 1 :1 mixture of hormone-supplemented F-12 medium and DME conditioned by 3T3 fibroblasts for 4 d. All confluent cultures showed transepithelial electric potentials characteristic ofCF and non-CF cells as previously noted ( 12 (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) Ci/mmol) (20 MCi/ml) and carrier-free Na235SO4 (100 jCi/ml), or [3H]serine (7) (8) Ci/mmol) (40 ,Ci/ml) and Na35SO4 (100 uCi/ml), added to either the apical or basolateral medium. Except where indicated, media were harvested daily and replaced with fresh media. Because steady state secretion of radiolabeled HMG is reached during the second day of culture (13) , the apical media on days 2-4 were combined. HMG were isolated on Sepharose CL-6B (Pharmacia Fine Chemicals, Piscataway, NJ) (14) and quantitated by liquid scintillation counting. In all experiments, pairs of CF and normal cells or normal and DC cells were handled identically and studied in parallel.
Trypsin treatment ofcultured cells. Cultured cells were exposed to porcine pancreatic trypsin (300 U/ml medium) added to the apical compartment for 30 min. Soybean trypsin inhibitor was then introduced at a final concentration of 200 ,ug/ml, before isolation and quantitation of HMG as described above. Cultured cells exposed to trypsin or medium alone were fixed in 2% formaldehyde 2% glutaraldehyde at 4°C overnight before Epon embedding for electron microscopy.
Other methods. Amino acid composition of HMG was determined by an HPLC procedure modified from that of Bidlinmeyer et al. (15) .
Modifications include addition of 200 mM boric acid to the acetate buffer and the utilization of an internal standard, 6-amino-n-hexanoic acid, which is eluted 1-2 min before tyrosine. CsCl (Table I ). 35S/3H(GlcN) ratios for HMG released by normal and DC cells were not different. The abnormally higher ratio is due to increased 35S label associated with HMG and not underglycosylation because the release rate of I5S label associated with HMG (dpm/mm2 surface area) during a 24-h period by CF cells (1.98±0.32 X 103) (n = 21 collagen matrices from 11 donors) was greater than that of normal cells (1.16±0.21 X 103) (n = 20 collagen matrices from 10 donors) (P < 0.05) whereas the rate of release of 3H label associated with HMG was not different for CF (8.94±1.69 X 103) (n = 21) and normal cells (9.82±1.82 X I03) (n = 20) (P > 0.5). Second, when [3H]GlcN was replaced with [3H]Ser in double-labeling experiments to normalize sulfate to peptide content, the 3"S/3H(Ser) ratio for the HMG released by CF cells was threefold higher than that of the HMG released by normal and DC cells (Table II) . Again, no difference was detected for 35S/3H(Ser) ratios of HMG released from normal and DC cells. We further verified that the rate of release of HMG expressed as peptide content (,ug/d-cm2 surface area), HMG released into media by cultured cells contain several classes of glycoconjugates (13) . Therefore, we examined whether oversulfation of HMG is a general phenomenon or is limited to a specific class of HMG. When HMG isolated from apical media were treated with bovine testicular hyaluronidase, 49% of the 3H(GlcN)-label and 35% of the 35S label were liberated from HMG, suggesting that glycosaminoglycans such as chondroitin sulfates, dermatan sulfate, and hyaluronic acid are released into the medium (16) . The mean 35S/3H(GlcN) ratio for hyaluronidase-susceptible HMG (glycosaminoglycans) released by CF cells (0.21±0.05) (n = 12) was 3.5 times that for glycosaminoglycans from normal cells (0.06±0.01) (n = 21) (P < 0.001). Similarly, the mean 35S/3H(GlcN) ratio of hyaluronidase-resistant HMG from CF cells (0.26±0.02) (n = 12) was 50% higher than that from normal cells (0. 17±0.01) (n = 21) (P < 0.001). Approximately 40% of N-acetylgalactosamine in hyaluronidase-resistant HMG was converted to Nacetylgalactosaminitol after alkaline borohydride treatment (17) , suggesting that these HMG contain mucin-type carbohydrate to peptide linkages. The mucin-type HMG from CF cells were more heterogeneous than control HMG with respect to density (Fig. 1, A and B) . The peak buoyant density of hyaluronidase-resistant HMG released by normal cells was 1.52 and 1.53 g/ml for 3H label and 35S label, respectively (Fig. 1 A) . The peak buoyant density of hyaluronidase-resistant HMG released by CF cells was 1.55 and 1.59 g/ml for 3H label and 35S label, respectively (Fig. 1 B) . Because sulfate is more dense than either carbohydrates (18) or amino acids (19) , these results are consistent with increased sulfation of CF mucintype HMG.
Increased sulfation ofcell surface HMG. Oversulfation was not limited to CF HMG spontaneously released into the medium. CF HMG released from the cell surface by trypsin had a 35S/3H(Ser) ratio 3-4-fold greater than that of normal or disease control HMG (Table III) . Electron microscopy of the apical membranes ofcultured cells treated with trypsin showed substantial loss of glycocalyx over tips of microvilli (Fig. 2) , suggesting that the HMG released by trypsin are at least in part associated with the apical cell surface. <00(DvsCF * After media were harvested on day 4, the cultured cells were exposed to porcine pancreatic trypsin as described in the text. Tissue donors and culture conditions are described in Table II. as indices of peptide, carbohydrate, and sulfate contents, respectively. The higher 35S/3H (GlcN or ser) ratios for CF HMG as compared to non-CF HMG indicate that sulfation relative to glycosylation or peptide synthesis is increased in CF cells. Because rates of release of 3H(GlcN)-label associated with HMG and HMG peptide measured chemically are not different statistically between CF and non-CF cells while rate of release of 3"S04-label associated with HMG is significantly higher in CF as compared with non-CF cells, we conclude that CF HMG are more heavily sulfated than non-CF HMG. Higher buoyant density exhibited by CF mucin-type HMG is consistent with this conclusion. Previous studies demonstrating increased sulfation of HMG secreted by CF airways in situ (8) or in organ culture (9, 10) have been interpreted by some to reflect an acquired abnormality, perhaps related to intensity of chronic airway inflammation (11) . However, our studies show that increased sulfation of CF HMG persists during primary culture of nasal epithelial cells, whereas HMG synthesized by DC nasal epithelial cells in culture are not oversulfated as compared with normal controls. Therefore, oversulfation of CF HMG can not be attributed to the effects of chronic airways inflammation. We propose that increased sulfation of HMG is closely related to the fundamental biochemical abnormality in CF epithelial cells. Our observation that glycosaminoglycans as well as mucin-type HMG released spontaneously from cultured cells and cell surface HMG are oversulfated suggest that the CF sulfation abnormality affects many or all sulfated respiratory epithelial macromolecules.
Cellular events that potentially modulate the sulfation of HMG are illustrated in Fig. 3 A. These include (a) translocation of sulfate ions across the plasma membrane by exchange or conductive pathways identified in human skin fibroblasts (20) and toad skin (21) , respectively; (b) intracellular generation of sulfate from sulfur-containing amino acids (22) ; (c) formation of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) from inorganic sulfate (22) ; and (d) transport of PAPS across the Golgi membrane to provide the sulfate donor for the synthesis of sulfated macromolecules in the Golgi apparatus (23 Fig. 3 B, several previously described abnormalities of CF epithelial cell ion transport or metabolic pathways could perturb the kinetics of the S04= pool: (a) abnormal regulation (1) (2) (3) (4) (5) of a putative cellular S04= transporter (20) ; (b) increased ATP supplies (24) ; and/or (c) alteration of a functional anion conductance that would limit the efflux of intracellular S04- (21) .
Current evidence suggests that CF epithelial cell dysfunction, particularly abnormal Cl-(and perhaps Na+) translocation across the apical membrane, can be traced to a malfunctioning regulatory step downstream from the regulatory kinases (1) (2) (3) (4) (5) (6) . A projected consequence of this ion transport dysfunction is a failure to provide water in adequate amounts for hydration of airways surface liquids, which may alter the viscoelastic properties of mucous gels (25, 26) . Increased sulfation of HMG also may contribute to altered physical properties of mucus (27) tion ofCF airways by selective microbial pathogens. For example, patients with other genetic diseases that lack mucociliary clearance generally are not infected with these microorganisms and do not usually succumb to lung disease in the first two to three decades of life (7) . We speculate that oversulfated epithelial HMG provide a clue to the selection of P. aeruginosa and S. aureus in CF airways by (a) providing a favored site for binding of these bacteria (28, 29) at epithelial cell surfaces and/or (b) adversely influencing the interaction between HMG components of airways secretions and specific microorganisms (8) .
